Epoprostenol Sodium Patents

Given below is the list of patents protecting Epoprostenol Sodium, along with the drug name that holds that patent and the company name owning that drug.

A patent's expiry date may change depending upon legal activities going on that patent. Critical activities like abandoning of a patent, term extension of a patent or amendment of its claims can increase or decrease the life of a patent hence affecting its expiry date and in turn affecting the generic launch date of that drug. Tracking these ongoing activities on a patent application helps to keep an eye on the latest developments in the patent process of the drug which can give an idea of how early a drug's generic could be available. The next section provides a list of recent legal activities on Epoprostenol Sodium's patents.

Latest Legal Activities on Epoprostenol Sodium's Patents

Given below is the list recent legal activities going on the following patents of Epoprostenol Sodium.

Activity	Date	Patent Number
Today's Critical Events
Payment of Maintenance Fee, 12th Year, Large Entity	15 May, 2024	US8318802
Payment of Maintenance Fee, 8th Year, Large Entity	19 May, 2021	US8598227
Payment of Maintenance Fee, 8th Year, Large Entity	14 May, 2020	US8318802
Email Notification Critical	05 Sep, 2014	US8598227
Change in Power of Attorney (May Include Associate POA) Critical	05 Sep, 2014	US8598227
Filing Receipt - Replacement	05 Sep, 2014	US8598227
Electronic Review Critical	23 Jul, 2014	US8598227
Email Notification Critical	23 Jul, 2014	US8598227
Mail Pre-Exam Notice	23 Jul, 2014	US8598227
Change in Power of Attorney (May Include Associate POA) Critical	22 Jul, 2014	US8318802

Epoprostenol Sodium's Family Patents

Full family tree